Clinical trial

A Pilot Study to Understand the Impact of Therapy With Tumour Treating Fields (TTFields) in NSCLC

NCT05698264

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2023-01-20

PhaseNA

Study timeline

Study start (estimated)2023-01-20Date precision: day

Registry last updated2023-01-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non Small Cell Lung Cancerunresolved

EGFR Gene Mutationunresolved

Immune Checkpoint Inhibitorunresolved

Interventions

concomitant TTFields treatment device to standard of care EGFR positive NSCLC treatmentDEVICE

concomitant TTFields treatment device to standard of care anti PD-1 NSCLC treatmentDEVICE

Sponsors & collaborators

Nir Peledlead sponsor

Mapped research locations

JerusalemIsrael1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05698264 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.